Trial · NCT07329660
Crystalloid vs Colloid for Hemodynamics During Anesthesia Induction in TAVR Patients
NCT07329660, Not applicable, Not yet recruiting, Air Force Military Medical University, China
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Crystalloid vs Colloid for Hemodynamics During Anesthesia Induction in TAVR Patients. Trials, record NCT07329660. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07329660
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Crystalloid vs Colloid for Hemodynamics During Anesthesia Induction in TAVR Patients
- NCT number
- NCT07329660
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 116 participants, estimated
- Lead sponsor
- Air Force Military Medical University, China
- Conditions
- Transcatheter Aortic Valve Replacement, Hemodynamic Stability, Anesthesia Induction
- Interventions
- Hydroxyethyl starch 130/0.4, Lactate Ringer's Solution
- First posted
- 2026-01-09
- Last updated
- 2026-02-27
Source ClinicalTrials.gov
Registered outcomes9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | The area under curve (AUC) of the change in mean arterial pressure from baseline during the induction period. | induction period, at an average of 15 minutes | The AUC below baseline MAP is calculated as: ∑ (((Si - Sbaseline)+(Si-1 - Sbaseline))/2 × ΔX) where Sbaseline is the baseline MAP, Si is the MAP at minute i (i = 0.5, 1, 1.5…15), and ΔX is the time interval between measurements. |
| Secondary | Incidence of post-induction hemodynamic instability, defined as arterial pressure (MAP)< 65 mmHg or a decrease of more than 20% from baseline within 15 minutes after induction. | 15 minutes after induction | |
| Secondary | Intraoperative use of vasoactive drugs. | Intraoperative period, at an average of 2 hours | |
| Secondary | Sequential Organ Failure Assessment(SOFA )score on the first postoperative day | The first postoperative day, at 24 hours after surgery | SOFA score grades organ dysfunction from 0 (normal) to 4 (most abnormal) for six organ systems . The total score is the sum of all six sub-scores, ranging from 0 to 24 . The higher score means the worse organ function. |
| Secondary | Length of hospital stay. | The duration of the patient's hospitalization after the initial surgery, at an average of 5 days. | |
| Secondary | Proportion of patients admitted to the intensive care unit (ICU) after surgery | During the postoperative period prior to discharge (at an average of 5 days) | |
| Secondary | In-hospital all-cause mortality | During the postoperative period prior to discharge (at an average of 5 days) | |
| Secondary | All-cause mortality within 30 days postoperatively | 30 days after surgery | |
| Secondary | Proportion of patients receiving renal replacement therapy during the 30-day postoperative observation period | 30 days after surgery |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 42902397 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07329660
GET https://conductscience.org/api/trials/v1/NCT07329660/registered